Skip to content

This content is in French.

Metformin and simvastatin in ovarian cancer

20 mars 2024

Metformin and simvastatin in ovarian cancer

Ovarian cancer is the most lethal gynecological malignancy. One approach to developing effective new therapeutic strategies is to redirect drugs already on the market for other indications. In this study…

Sign in to read the rest

Reserved for healthcare professionals, free registration.

Scientific reference

Sara Mikhael et al. Evaluating synergistic effects of metformin and simvastatin on ovarian cancer cells. PLoS One. 2024 Mar 15;19(3):e0298127.

View the source